Search

Can yeast-based vaccines help overcome global vaccine inequity challenges?

Three companies – Cardinal Health, REGENXBIO, and Beacon Therapeutics – help us explore gene therapy development in the ophthalmic space

The story of how Caribou Biosciences developed a hybrid RNA-DNA guide to increase Cas9 specificity.

Cerevel Therapeutics' Emraclidine - in development for schizophrenia and Alzheimer’s disease psychosis - yields positive results in phase Ib trial

Exploring the potential of hybrid peptide-DNA nanostructures and artificial life

How multi-omics and AI-driven target identification can drive the future of personalized medicine

A deep dive into the dangers of fentanyl entering the US supply chain – and the importance of the Drug Supply Chain Security Act

How a three-way collaboration aims to use digital twins to refine the efficiency of adeno-associated virus manufacture

AskBio CEO Sheila Mikhail shares the story behind her success and her strength

Howard Fillit shares his views on the historical research lag, the slim successes so far, and the target pathways that offer most hope